Enhanced endothelialization of a new stent polymer through surface enhancement and incorporation of growth factor-delivering microparticles

Journal of Cardiovascular Translational Research

Volumn 5, Issue 4, 2012, Pages 519-527

  Xu, Hao ^a   Nguyen, Kytai T ^b   Brilakis, Emmanouil S ^a,c   Yang, Jian ^b   Fuh, Eric ^a   Banerjee, Subhash ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

^c VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Endothelial progenitor cells; Endothelialization; Microparticle; Poly 1,8 octanediol co citric acid polymer

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 1BETA; POLY 1,8 OCTANEDIOL CO CITRIC ACID; POLYGLACTIN; POLYMER; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CELL ADHESION; CELL PROLIFERATION; CHEMICAL REACTION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIALIZATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MATERIAL COATING; PRIORITY JOURNAL; STENT; THROMBOCYTE ACTIVATION; THROMBOGENICITY;

ANTIBODIES; ANTIGENS, CD34; BLOOD COAGULATION; BLOOD PLATELETS; CELL ADHESION; CELL PROLIFERATION; CELLS, CULTURED; CITRATES; COATED MATERIALS, BIOCOMPATIBLE; DRUG CARRIERS; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; HEMOLYSIS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; LACTIC ACID; MATERIALS TESTING; P-SELECTIN; PARTICLE SIZE; PLATELET ACTIVATION; POLYGLYCOLIC ACID; POLYMERS; PROSTHESIS DESIGN; STEM CELLS; STENTS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84866133421     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-012-9381-8     Document Type: Article

References (46)

1. Holmes, D. R., Jr., Kereiakes, D. J., Laskey, W. K., Colombo, A., Ellis, S. G., Henry, T. D., et al. (2007). Thrombosis and drugeluting stents: an objective appraisal. Journal of the American College of Cardiology, 50(2), 109-118. doi:10.1016/ j.jacc.2007.04.032.
2. Joner, M., Finn, A. V., Farb, A., Mont, E. K., & Virmani, R. (2006). Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. Journal of the American College of Cardiology, 48, 193-202.
3. Joner, M., Nakazawa, G., Finn, A. V., Quee, S. C., Coleman, L., Acampado, E., et al. (2008). Endothelial cell recovery between comparator polymer-based drug-eluting stents. Journal of the American College of Cardiology, 52(5), 333-342. doi:10.1016/ j.jacc.2008.04.030.
4. Notaristefano, S., Sbarzaglia, P., & Cavallini, C. (2008). Late stent thrombosis after drug-eluting stent implantation: epidemiological, clinical and pathophysiological aspects. G Ital Cardiol (Rome), 9 (10), 674-683.
5. Joner, M., Nakazawa, G., & Fine, A. V. (2008). Endothelial cell recovery between comparator polymer-based drug-eluting stents. Journal of the American College of Cardiology, 52(5), 333-342.
6. Yang, J., Webb, A. R., & Ameer, G. A. (2004). Novel citric acidbased biodegradable elastomers for tissue engineering. Advanced Materials, 16, 511-516.
7. Tinsley-Bown, A. M., Fretwell, R., Dowsett, A. B., Davis, S. L., & Farrar, G. H. (2000). Formulation of poly(D, L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. Journal of Controlled Release, 66(2-3), 229-241.
8. Markowicz, M., Koellensperger, E., Neuss, S., Koenigschulte, S., Bindler, C., & Pallua, N. (2006). Human bone marrow mesenchumal stem cell seeded on modified collagen improved dermal regenration in vivo. Cell Transplantation, 15(8-9), 723-732.
9. Xu, H., Deshmukh, R. R., Timmons, R. B., & Nguyen, K. T. (2010). Enhanced endothelialization on surface modified poly (L-lactic acid) substrates. Tissue Eng Part A. doi:10.1089/ ten.TEA.2010.0129.
10. Södergård, A., & Stolt, M. (2002). Properties of lactic acid based polymers and their correlation with composition. Progress in Polymer Science, 27(6), 1123-1163. doi:10.1016/s0079-6700(02) 00012-6.
11. Tamada, Y., Kulik, E. A., & Ikada, Y. (1995). Simple method for platelet counting. Biomaterials, 16(3), 259-261.
12. Choudhury, A., Chung, I., Blann, A. D., & Lip, G. Y. (2007). Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm. Journal of the American College of Cardiology, 49(19), 1957-1964. doi:10.1016/ j.jacc.2007.02.038.
13. Huang, N., Yang, P., Leng, Y. X., Chen, J. Y., Sun, H., Wang, J., et al. (2003). Hemocompatibility of titanium oxide films. Biomaterials, 24(13), 2177-2187.
14. Motlagh, D., Yang, J., Lui, K. Y., Webb, A. R., & Ameer, G. A. (2006). Hemocompatibility evaluation of poly(glycerol-sebacate) in vitro for vascular tissue engineering. Biomaterials, 27(24), 4315-4324. doi:10.1016/j.biomaterials.2006.04.010.
15. Ingram, D. A., Mead, L. E., Tanaka, H., Meade, V., Fenoglio, A., Mortell, K., et al. (2004). Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood, 104(9), 2752-2760. doi:10.1182/blood-2004- 04-13962004-04-1396.
16. Eggermann, J., Kliche, S., Jarmy, G., Hoffmann, K., Mayr-Beyrle, U., Debatin, K. M., et al. (2003). Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood. Cardiovascular Research, 58 (2), 478-486.
17. Caron, A., Theoret, J. F., Mousa, S. A., & Merhi, Y. (2002). Antiplatelet effects of GPIIb/IIIa and P-selectin antagonism, platelet activation, and binding to neutrophils. Journal of Cardiovascular Pharmacology, 40(2), 296-306.
18. Virmani, R., Kolodgie, F. D., Farb, A., & Lafont, A. (2003). Drug eluting stents: are human and animal studies comparable? Heart, 89(2), 133-138.
19. Finn, A. V., Nakazawa, G., & Joner, M. (2007). Vascular responses to drug eluting stents: importance of delayed healing. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(7), 1500-1510.
20. Padfiled, G. J., Newby, D. E., & Mills, N. L. (2010). Understanding the role of endothelial progenitor cells in percutaneous coronary intervention. Journal of the American College of Cardiology, 55(15), 1553-1565.
21. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., et al. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275(5302), 964-967.
22. Abou-Saleh, H., Yacoub, D., Theoret, J. F., Gillis, M. A., Neagoe, P. E., Labarthe, B., et al. (2009). Endothelial progenitor cells bind and inhibit platelet function and thrombus formation. Circulation, 120(22), 2230-2239. doi:10.1161/CIRCULATIONAHA. 109.894642.
23. Banerjee, S., Brilakis, E., Zhang, S., Roesle, M., Lindsey, J., Philips, B., et al. (2006). Endothelial progenitor cell mobilization after percutaneous coronary intervention. Atherosclerosis, 189(1), 70-75. doi:10.1016/j. atherosclerosis.2006.04.026.
24. Shirota, T., Yasui, H., Shimokawa, H., & Matsuda, T. (2003). Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials, 24(13), 2295-2302.
25. Rotmans, J. I., Heyligers, J. M., Verhagen, H. J., Velema, E., Nagtegaal, M. M., de Kleijn, D. P., et al. (2005). In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation, 112 (1), 12-18. doi:10.1161/CIRCULATIONAHA.104.504407.
26. Markway, B. D., McCarty, O. J., Marzec, U. M., Courtman, D. W., Hanson, S. R., & Hinds, M. T. (2008). Capture of flowing endothelial cells using surface-immobilized anti-kinase insert domain receptor antibody. Tissue Engineering. Part C, Methods, 14(2), 97-105. doi:10.1089/tec.2007.0300.
27. Blindt, R., Vogt, F., Astafieva, I., Fach, C., Hristov, M., Krott, N., et al. (2006). A novel drug-eluting stent coated with an integrinbinding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. Journal of the American College of Cardiology, 47(9), 1786-1795. doi:10.1016/ j.jacc.2005.11.081.
28. Taite, L. J., Yang, P., Jun, H.W., &West, J. L. (2008). Nitric oxidereleasing polyurethane-PEG copolymer containing the YIGSR peptide promotes endothelialization with decreased platelet adhesion. Journal of Biomedical Materials Research. Part B, Applied Biomaterials, 84(1), 108-116. doi:10.1002/jbm.b.30850.
29. Veleva, A. N., Heath, D. E., Cooper, S. L., & Patterson, C. (2008). Selective endothelial cell attachment to peptide-modified terpolymers. Biomaterials, 29(27), 3656-3661. doi:10.1016/ j.biomaterials.2008.05.022.
30. Hoffmann, J., Paul, A., Harwardt, M., Groll, J., Reeswinkel, T., Klee, D., et al. (2008). Immobilized DNA aptamers used as potent attractors for porcine endothelial precursor cells. Journal of Biomedical Materials Research. Part A, 84(3), 614-621. doi:10.1002/ jbm.a.31309.
31. Aoki, J., Serruys, P.W., van Beusekom, H., Ong, A. T., McFadden, E. P., Sianos, G., et al. (2005). Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. Journal of the American College of Cardiology, 45(10), 1574-1579.
32. Granada, J. F., Inami, S., Aboodi, M. S., Tellez, A., Milewski, K., Wallace-Bradley, D., et al. (2010). Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix. Circulation. Cardiovascular Interventions, 3(3), 257-266. doi:10.1161/ CIRCINTERVENTIONS.109.919936.
33. Conklin, B. S., Wu, H., Lin, P. H., Lumsden, A. B., & Chen, C. (2004). Basic fibroblast growth factor coating and endothelial cell seeding of a decellularized heparin-coated vascular graft. Artificial Organs, 28 (7) , 668-675. doi :10.1111/ j .1525-1594. 2004.00062.xAOR00062.
34. Hristov, M., Erl, W., &Weber, P. C. (2003). Endothelial progenitor cells: mobilization, differentiation, and homing. Arteriosclerosis, Thrombosis, and Vascular Biology, 23(7), 1185-1189. doi :10.1161/01.ATV.0000073832.49290. B501.ATV. 0000073832.49290.B5.
35. Hirota, K., Hasegawa, T., Nakajima, T., & Terada, H. (2010). Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis. Journal of Controlled Release, 142(3), 339-346.
36. Xanthe, M. L., Eileen, T. D., Ann, L. D., Nancy, L., & Jeffery, L. C. (2000). Sustained release of recombinant human insulin-like growth factor-1 for treatment of diabetes. Journal of Controlled Release, 67, 281-292.
37. Mayo, A. S., Ambati, B. K., & Kompella, U. B. (2010). Gene delivery nanoparticles fabricated by supercritical fluoid extraction of emulsions. International Journal of Pharmaceutics, 387(1-2), 275-285.
38. Giteau, A., Venier-Juilenne, M. C., Aubert-Pouessel, A., & Benoit, J. P. (2008). How to achieve sustained and complete protein release from PLGA-based microparticles? International Journal of Pharmaceutics, 350(1-2), 14-26.
39. Klose, D., Siepmann, F., Willart, J. F., Descamps, M., & Siepmann, J. (2010). Drug release from PLGA-based microparticles: effects of the "microparticle:bulk fluid" ratio. International Journal of Pharmaceutics, 383(1-2), 123-131. doi:10.1016/ j.ijpharm.2009.09.012.
40. Yang, J., Webb, A. R., Pickerill, S. J., Hageman, G., & Ameer, G. A. (2006). Synthesis and evaluation of poly(diol citrate) biodegradable elastomers. Biomaterials, 27(9), 1889-1898.
41. Ito, F., Fujimori, H., & Makino, K. (2007). Incorporation of watersoluble drugs in PLGA microspheres. Colloids and Surfaces. B, Biointerfaces, 54(2), 173-178. doi:10.1016/j.colsurfb. 2006.10.019.
42. Chin-Quee, S. L., Hsu, S. H., Nguyen-Ehrenreich, K. L., Tai, J. T., Abraham, G. M., Pacetti, S. D., et al. (2010). Endothelial cell recovery, acute thrombogenicity, and monocyte adhesion and activation on fluorinated copolymer and phosphorylcholine polymer stent coatings. Biomaterials, 31(4), 648-657. doi:10.1016/ j.biomaterials.2009.09.079.
43. Vedantham, K., Chaterji, S., Kim, S. W., & Park, K. (2012). Development of a probucol-releasing antithrombogenic drug eluting stent. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. doi:10.1002/jbm.b.32672.
44. Zheng, W., Wang, Z., Song, L., Zhao, Q., Zhang, J., Li, D., et al. (2012). Endothelialization and patency of RGD-functionalized vascular grafts in a rabbit carotid artery model. Biomaterials, 33 (10), 2880-2891. doi:10.1016/j.biomaterials.2011.12.047.
45. Jia, H., Liu, H., Kong, J., Hou, J., Wu, J., Zhang, M., et al. (2011). A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model. Journal of Biomedical Materials Research. Part A, 98(4), 629-637. doi:10.1002/ jbm.a.33151.
46. Ramchandani, M., & Robinson, D. (1998). In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants. Journal of Controlled Release, 54(2), 167-175.